This guide is for informational purposes only. Always refer to the official current edition of the European Pharmacopoeia for legally binding requirements.
: Tablets designed to disperse rapidly in the mouth or dissolve in water before administration. 3. Production and Quality Control Requirements European Pharmacopoeia -ph. Eur.- Monograph Tablets -0478-
In the complex world of pharmaceutical manufacturing, consistency isn't just a goal—it's a legal requirement. For anyone operating within the 39 member states of the European Pharmacopoeia Convention European Pharmacopoeia (Ph. Eur.) Monograph 0478 This guide is for informational purposes only
The monograph emphasizes that the manufacturing process must ensure: the International Pharmacopoeia
Beyond Europe, the monograph serves as a reference for the World Health Organization (WHO), the International Pharmacopoeia, and regulatory bodies in countries like Australia, Canada, and Japan. Many manufacturers globally design their tablet production processes to meet Ph. Eur. 0478 criteria to facilitate entry into the European market. The monograph also evolves; recent revisions have incorporated stricter limits for nitrosamine impurities (via cross-reference to general chapter 2.5.42) and updated dissolution apparatus calibration requirements.